Related Experiment Video
Updated: Jul 9, 2026

In vitro Cell Migration and Invasion Assays
Published on: June 1, 2014
Aminopeptidase N (APN)/CD13-dependent CXCR4 downregulation is associated with diminished cell migration,
Jens Wulfaenger1, Susanna Niedling, Dagmar Riemann
1Martin-Luther-University, Institute of Medical Immunology, Halle-Wittenberg, Germany.
Abstract:
Aminopeptidase N (APN/CD13) is a 150 kDa membrane-bound ubiquitously expressed protease with a broad functional repertoire. It hydrolyzes small peptide mediators, modulates cell motility and adhesion to extracellular matrix and also acts as a viral receptor. In order to dissect the function of enzymatically active and inactive APN/CD13, substitutions of different enzymatic active amino acid residues were generated by site-directed mutagenesis and stably transfected into human embryonic kidney cells. All APN variants analyzed exhibited a complete loss of enzymatic activity, whereas wild type APN transfectants exerted a strong aminopeptidase-specific activity. Furthermore, wild type APN expression was associated with a significant decrease in proliferation, migration and also reduced anchorage-independent growth when compared to enzymatically inactive APN variants and controls. This appeared to be due to a downregulated mRNA and protein expression of the chemokine receptor CXCR4 and an inhibition of the stromal cell-derived factor (SDF)-1alpha/CXCL12-mediated migration. Thus, high APN enzyme activity may antagonize the cellular properties regulated by the CXCR4/SDF-1alpha system in embryonic kidney cells.
Insights
Enzymatically active Aminopeptidase N (APN/CD13) significantly reduces kidney cell proliferation and migration. This occurs by downregulating the CXCR4 receptor, antagonizing SDF-1alpha/CXCL12 signaling.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Biology
Background:
- Aminopeptidase N (APN/CD13) is a ubiquitous membrane-bound protease with diverse functions, including peptide hydrolysis, cell motility modulation, and viral receptor activity.
- Understanding the distinct roles of enzymatically active versus inactive APN/CD13 is crucial for elucidating its biological significance.
Purpose of the Study:
- To investigate the functional differences between enzymatically active and inactive Aminopeptidase N (APN/CD13) in human embryonic kidney cells.
- To determine the impact of APN/CD13 enzymatic activity on cell proliferation, migration, and anchorage-independent growth.
Main Methods:
- Site-directed mutagenesis was used to create enzymatically inactive APN/CD13 variants.
- These variants and wild-type APN were stably transfected into human embryonic kidney cells.
- Cell proliferation, migration, anchorage-independent growth, CXCR4 expression, and SDF-1alpha/CXCL12-mediated migration were analyzed.
Main Results:
- Wild-type APN transfectants displayed strong enzymatic activity, while all variants were inactive.
- Active APN expression significantly decreased cell proliferation, migration, and anchorage-independent growth compared to inactive variants and controls.
- This effect was linked to downregulated mRNA and protein expression of the chemokine receptor CXCR4 and inhibited SDF-1alpha/CXCL12-mediated migration.
Conclusions:
- High Aminopeptidase N enzyme activity antagonizes cellular properties regulated by the CXCR4/SDF-1alpha system in embryonic kidney cells.
- The enzymatic function of APN/CD13 plays a critical role in modulating cell behavior beyond its protease activity.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Cell Migration
Chemotaxis and Direction of Cell Migration
Anaphase Promoting Complex
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...

